Citation Indices
|
All
|
Since 2019
|
Citation
|
231
|
195
|
h-index
|
7
|
6
|
i10-index
|
3
|
3
|
Acceptance Rate (By Year)
|
|
Year
|
Percentage
|
2023
|
10.84%
|
2022
|
9.14%
|
2021
|
11.26%
|
2020
|
11.8%
|
2019
|
10.3%
|
2018
|
8.65%
|
2017
|
12.9%
|
2016
|
10.9%
|
2015
|
12.5%
|
DOI: 10.25125/medical-journal
IMJ Health: A Member of CrossRef USA
WorldCat, Tyndale University Publons, Indiana University, Index Copernicus
Editor-in-Chief: Dr. Kusum Gaur
ISSN: 2395-6291
Frequency: Monthly (12 issues per year)
DOI: 10.25125/medical-journal
Submit Article Online: Click here to Submit
Send Article to E-mail: info@imjhealth.org or info.imjh@gmail.com
Guidelines to Authors: Click here to get Details
Language of Publication: English
Nature: Refereed/Peer-Reviewed Engineering Journal
Year of Commencement: 2015
Rwanda, often recognized for its rapid socio-economic development and commitment to health care, has emerged as a leader in health innovation within Africa. The country has made significant strides in improving health outcomes through innovative programs, strong political will, and partnerships with international health organizations. Rwanda’s health sector has been shaped by a focus on equitable access to care, making it a key player in Africa's medical and pharmaceutical research landscape.
Medical Journal: IMJ Health is a prestigious international journal committed to the rapid publication of high-quality original research in the fields of medical and pharmaceutical sciences. As a broad-based, open-access journal, IMJ Health welcomes groundbreaking research from across the globe. We are proud to be indexed and abstracted by major global databases, ensuring wide visibility and recognition for our authors.
At IMJ Health, we are dedicated to fostering a future where research is valued for its creativity, quality, and impact. Our mission is to motivate and guide researchers towards achieving a vision of "Total Egalitarian Research" while maintaining open communication with our editorial board and contributors.
Medical and pharmaceutical research in Rwanda is characterized by its commitment to solving the country’s pressing health challenges, including infectious diseases like HIV/AIDS, tuberculosis, and malaria, as well as non-communicable diseases like cancer and cardiovascular conditions. Rwanda is also pioneering in areas such as vaccine research, digital health technologies, and health system strengthening.
Additionally, Rwanda is building capacity in pharmaceutical sciences, aiming to become a hub for drug production and clinical trials in East Africa. The nation has invested heavily in research infrastructure, such as the establishment of the Rwanda Biomedical Centre (RBC) and collaborations with global research institutions. These efforts are designed to foster innovation and ensure that Rwanda's healthcare system is well-equipped to tackle emerging health issues.
Our journal is peer-reviewed, guaranteeing the quality and reliability of the research published within its pages. By publishing in IMJ Health, authors contribute to a valuable resource for medical professionals, researchers, and students worldwide.
By contributing to the medical and pharmaceutical research landscape, you are joining a global network of researchers dedicated to advancing health outcomes. IMJ Health invites professionals, academics, and institutions to share their innovative findings, collaborate on groundbreaking studies, and be part of a collective effort to improve healthcare worldwide. Together, we can address the challenges and opportunities in medical science and inspire the next generation of researchers.